Synthesised from both hydrophilic and hydrophobic monomers, the amphiphilic Adapt™ system provides exquisite control over drug release and can be easily tailored, through simple adjustment in the monomer ratios, to afford customised release profiles and bespoke physical properties.

Long-term stability, enhanced tissue and blood compatibility and highly tuneable drug delivery makes the Adapt™ Biostable Drug Delivery Platform ideally suited for site-targeted drug delivery applications, such as drug eluting stents.

For more information on Adapt™ please download our overview document.